Rheumatoid arthritis, atlantoaxial subluxation without neurological deficits. AADI 5-12 mm
Conditions
Interventions
Sponsors
None listed
Eligibility
Inclusion criteria
Inclusion criteria: 1. Rheumatoid Arthritis patients, seropositive; 2. Age 18-70; 3. Ranawat I and II: no neurological impairment; 4. C1-C2 subluxation: AADI: 5-12 mm; 5. C1-C2 subluxation reducible or irreducible; 6. Informed consent.
Exclusion criteria
Exclusion criteria: 1. Ranawat IIIA and IIIB: neurological impairment; 2. Severe comorbidity; 3. Previous craniocervical operations; 4. C1-C2 subluxation: AADI 12 mm or PADI < 10 mm; 5. MRI incompatibility.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome is the occurrence of a major event: 1. Neurological disability (paraesthesias, worsened Myelopathy Disability Index > 3 points); 2. Radiological progression (signs of myelopathy on MRI, impression of brainstem by vertical translocation, AADI > 12 mm, Vertical translocation); 3. Surgery (B) or resurgery (A) in case of progression to a stadium that longer wait and see will result in inevitable neurological deficit or death; 4. Death (all causes). | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcome measures are Ranawat, ASIA, DAS-28, VAS, EuroQol, SF-36, functional X-ray and MRI. The outcome will be evaluated at fixed intervals and a Kaplan Meier Survival Analysis will be performed. | — |
Contacts
Leiden University Medical Center (LUMC) P.O. Box 9600